세계의 HbA1c 검사 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global HbA1c Testing Market size is anticipated to grow from USD 2.22 Billion in 2024 to USD 6.27 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.2% during the forecast period of 2026 to 2033.

The HbA1c testing market is poised for significant growth, driven by the rising prevalence of diabetes and the increasing emphasis on preventive healthcare. As healthcare providers focus on early diagnosis and management of diabetes, HbA1c testing has emerged as a critical tool for monitoring long-term glucose control. This test not only aids in the diagnosis of diabetes but also plays a vital role in assessing the effectiveness of treatment regimens, making it indispensable in diabetes care.

Technological advancements in diagnostic testing are reshaping the HbA1c testing landscape. Innovations in point-of-care testing devices are enhancing accessibility and convenience, allowing patients to monitor their glucose levels more effectively. These devices provide rapid results, enabling timely interventions and personalized treatment plans. Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, is facilitating better patient engagement and adherence to treatment protocols, thereby improving overall health outcomes.

The growing awareness of the importance of diabetes management is also driving market expansion. Public health initiatives aimed at educating individuals about the risks associated with uncontrolled diabetes are prompting more people to seek regular testing. As healthcare systems increasingly prioritize value-based care, the demand for reliable and accurate HbA1c testing solutions is expected to rise. In this evolving environment, stakeholders are well-positioned to capitalize on the growth potential of the HbA1c testing market, driving innovation and improving patient care in the process.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

• Instruments
• Reagents
• Kits

By Technology

• Ion-exchange HPLC
• Enzymatic assay
• Affinity binding chromatography
• Turbidimetric inhibition immunoassay
• Others

By End User

• Hospitals and clinics
• Diagnostic laboratories
• Homecare
• research institution
• others
• COMPANIES PROFILED
• Abbott
• Bio-Rad Laboratories Inc.
• ARKRAY Inc.
• Danaher
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare GmbH
• TransAsia Bio-Medicals
• Trinity Biotech Ireland
• EKF Diagnostics
• Randox Laboratories Ltd.
• HemoCue India
• Eurolyser Diagnostica GmbH
• Sekisui Diagnostics
• Healio
• Diazyme Laboratories Inc.
• Beckman Coulter Inc.
• A. Menarini Diagnostics srl
• SEBIA
• PTS Diagnostics
• DiaSys Diagnostic Systems GmbH.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. HBA1C TESTING INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By End User
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HBA1C TESTING MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Instruments Historic and Forecast Sales By Regions
• 5.4. Reagents Historic and Forecast Sales By Regions
• 5.5. Kits Historic and Forecast Sales By Regions

6. GLOBAL HBA1C TESTING MARKET ANALYSIS BY TECHNOLOGY

• 6.1. Overview By Technology
• 6.2. Historical and Forecast Data Analysis By Technology
• 6.3. Ion-exchange HPLC Historic and Forecast Sales By Regions
• 6.4. Enzymatic assay Historic and Forecast Sales By Regions
• 6.5. Affinity binding chromatography Historic and Forecast Sales By Regions
• 6.6. Turbidimetric inhibition immunoassay Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL HBA1C TESTING MARKET ANALYSIS BY END USER

• 7.1. Overview By End User
• 7.2. Historical and Forecast Data Analysis By End User
• 7.3. Hospitals and clinics Historic and Forecast Sales By Regions
• 7.4. Diagnostic laboratories Historic and Forecast Sales By Regions
• 7.5. Homecare Historic and Forecast Sales By Regions
• 7.6. Research institution Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL HBA1C TESTING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HBA1C TESTING COMPANIES

• 9.1. HbA1c Testing Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF HBA1C TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Abbott
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Bio-Rad Laboratories Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. ARKRAY Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Danaher
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. F. Hoffmann-La Roche Ltd.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Siemens Healthcare GmbH
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. TransAsia Bio-Medicals
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Trinity Biotech Ireland
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. EKF Diagnostics
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Randox Laboratories Ltd.
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. HemoCue India
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Eurolyser Diagnostica GmbH
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments
• 10.15. Sekisui Diagnostics
  • 10.15.1 Company Overview
  • 10.15.2 Company Revenue
  • 10.15.3 Products
  • 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies